{"id":"ketotifen-fumarate-0-025-eye-drops","safety":{"commonSideEffects":[{"rate":"null","effect":"Eye irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking histamine receptors, ketotifen fumarate reduces the allergic response and inflammation in the eye, providing relief from itching, redness, and tearing associated with allergic conjunctivitis.","oneSentence":"Ketotifen fumarate is an antihistamine that works by blocking histamine receptors in the eye.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:17:53.347Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic conjunctivitis"}]},"trialDetails":[{"nctId":"NCT05815758","phase":"PHASE3","title":"Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2023-04-20","conditions":"Allergic Conjunctivitis","enrollment":512},{"nctId":"NCT05591755","phase":"PHASE3","title":"Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2022-11-18","conditions":"Seasonal Allergic Conjunctivitis","enrollment":229},{"nctId":"NCT05579730","phase":"PHASE3","title":"Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2022-10-12","conditions":"Allergic Conjunctivitis","enrollment":188},{"nctId":"NCT00769886","phase":"PHASE3","title":"Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2008-10","conditions":"Allergic Conjunctivitis","enrollment":144},{"nctId":"NCT03479307","phase":"PHASE3","title":"A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.","status":"COMPLETED","sponsor":"Faes Farma, S.A.","startDate":"2018-04-07","conditions":"Allergic Conjunctivitis","enrollment":228},{"nctId":"NCT00770133","phase":"PHASE3","title":"Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2010-02","conditions":"Allergic Conjunctivitis","enrollment":141},{"nctId":"NCT01326858","phase":"PHASE1","title":"Safety and Comfort of AL-4943A Ophthalmic Solution","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2011-04","conditions":"Allergic Conjunctivitis","enrollment":50},{"nctId":"NCT00426023","phase":"PHASE3","title":"Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis","status":"COMPLETED","sponsor":"Campus Bio-Medico University","startDate":"2007-02","conditions":"Vernal Keratoconjunctivitis","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zaditen collirio monodose"],"phase":"phase_3","status":"active","brandName":"ketotifen fumarate 0.025% eye drops","genericName":"ketotifen fumarate 0.025% eye drops","companyName":"Campus Bio-Medico University","companyId":"campus-bio-medico-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ketotifen fumarate is an antihistamine that works by blocking histamine receptors in the eye. Used for Allergic conjunctivitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}